Blog
Regeneron Moves to Strike and Dismiss Amgen’s Counterclaims in Aflibercept Litigation
On November 12, 2025, Regeneron filed a Motion to Strike Certain Affirmative Defenses and Dismiss Certain Counterclaims against Amgen in the aflibercept patent litigation in the U.S. District Court for the Northern District of West Virginia….
By: Goodwin